{
    "nct_id": "NCT06662058",
    "official_title": "Ototoxicity Monitoring and Remote Audiometry",
    "inclusion_criteria": "* Adult patients, male or female, aged â‰¥ 18, able to provide informed consent\n* Subjects with pathologically proven HNSCC involving the oral cavity, oropharynx, larynx, hypopharynx, nasopharynx, skin, or paranasal sinuses; patients with unknown primary HNSCC involving the cervical lymph nodes can also be included. Patients can have previously untreated or recurrent/metastatic disease\n* Subjects who will be treated with cisplatin chemotherapy and/or radiation. For radiation alone, patients should have tumors near the inner ear, including the nasopharynx, temporal bone, and/or parotid salivary gland\n* Life expectancy of more than 3 months, as determined by the investigator\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients with profound hearing loss in both ears, which precludes an accurate hearing test. This can be determined based on patient report/history or audiogram done before or after informed consent\n* Patients who are unable to participate in a hearing test (per the investigator's judgment)",
    "miscellaneous_criteria": ""
}